O. Fujishita, K. Kuroda, Y. Nakao, Y. Natori, M. Fukui, R. Oishi
{"title":"浓缩电解质注射制备人工脑脊液的研究。","authors":"O. Fujishita, K. Kuroda, Y. Nakao, Y. Natori, M. Fukui, R. Oishi","doi":"10.5649/JJPHCS1975.22.305","DOIUrl":null,"url":null,"abstract":"Two concentrated electrolyte injections (solution A and B) were used for the rapid and easy preparation of artificial cerebrospinal fluid (ACF). Solution A (10 ml) included Na, K, Mg, Ca, Cl, lactate, and glucose while solution B (20 ml) was composed of KH2 PO4 and NaHCO3. Solution A was first added to 0, 9% NaCl in jection (515 ml) maintained in a soft plastic bag followed by solution B. Notably, the prepared ACF had particulate matter counts far less than the Japanese pharmacopoeia (JP) and United States Pharmacopeia (USP) limits for large volume injections. Application of the present ACF to patients using a ventricular fiberscope caused no significant adverse effects, such as convulsion, headaches or fever.","PeriodicalId":17399,"journal":{"name":"Journal of the Nippon Hospital Pharmacists Association","volume":"82 1","pages":"305-309"},"PeriodicalIF":0.0000,"publicationDate":"1996-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Preparation of Artificial Cerebrospinal Fluid Using Concentrated Electrolyte Injections.\",\"authors\":\"O. Fujishita, K. Kuroda, Y. Nakao, Y. Natori, M. Fukui, R. Oishi\",\"doi\":\"10.5649/JJPHCS1975.22.305\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Two concentrated electrolyte injections (solution A and B) were used for the rapid and easy preparation of artificial cerebrospinal fluid (ACF). Solution A (10 ml) included Na, K, Mg, Ca, Cl, lactate, and glucose while solution B (20 ml) was composed of KH2 PO4 and NaHCO3. Solution A was first added to 0, 9% NaCl in jection (515 ml) maintained in a soft plastic bag followed by solution B. Notably, the prepared ACF had particulate matter counts far less than the Japanese pharmacopoeia (JP) and United States Pharmacopeia (USP) limits for large volume injections. Application of the present ACF to patients using a ventricular fiberscope caused no significant adverse effects, such as convulsion, headaches or fever.\",\"PeriodicalId\":17399,\"journal\":{\"name\":\"Journal of the Nippon Hospital Pharmacists Association\",\"volume\":\"82 1\",\"pages\":\"305-309\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Nippon Hospital Pharmacists Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5649/JJPHCS1975.22.305\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Nippon Hospital Pharmacists Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/JJPHCS1975.22.305","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Preparation of Artificial Cerebrospinal Fluid Using Concentrated Electrolyte Injections.
Two concentrated electrolyte injections (solution A and B) were used for the rapid and easy preparation of artificial cerebrospinal fluid (ACF). Solution A (10 ml) included Na, K, Mg, Ca, Cl, lactate, and glucose while solution B (20 ml) was composed of KH2 PO4 and NaHCO3. Solution A was first added to 0, 9% NaCl in jection (515 ml) maintained in a soft plastic bag followed by solution B. Notably, the prepared ACF had particulate matter counts far less than the Japanese pharmacopoeia (JP) and United States Pharmacopeia (USP) limits for large volume injections. Application of the present ACF to patients using a ventricular fiberscope caused no significant adverse effects, such as convulsion, headaches or fever.